Annual Debt To Equity
0.02
0.000.00%
December 31, 2023
Summary
- As of February 7, 2025, IKT annual debt to equity ratio is 0.02, unchanged on December 31, 2023.
- During the last 3 years, IKT annual debt to equity has fallen by -0.01 (-33.33%).
- IKT annual debt to equity is now -33.33% below its all-time high of 0.03, reached on December 31, 2020.
Performance
IKT Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Debt To Equity
-0.27
-0.30-1000.00%
September 30, 2024
Summary
- As of February 7, 2025, IKT quarterly debt to equity ratio is -0.27, with the most recent change of -0.30 (-1000.00%) on September 30, 2024.
- Over the past year, IKT quarterly debt to equity has dropped by -0.30 (-1000.00%).
- IKT quarterly debt to equity is now -280.00% below its all-time high of 0.15, reached on March 31, 2021.
Performance
IKT Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
IKT Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | -1000.0% |
| 3 y3 years | -33.3% | -2800.0% |
| 5 y5 years | +106.7% | -2800.0% |
IKT Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.0% | -1000.0% | at low |
| 5 y | 5-year | -33.3% | +125.0% | -280.0% | at low |
| alltime | all time | -33.3% | +106.7% | -280.0% | at low |
Inhibikase Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -0.27(-1000.0%) |
| Jun 2024 | - | 0.03(0.0%) |
| Mar 2024 | - | 0.03(+50.0%) |
| Dec 2023 | 0.02(0.0%) | 0.02(0.0%) |
| Sep 2023 | - | 0.02(0.0%) |
| Jun 2023 | - | 0.02(+100.0%) |
| Mar 2023 | - | 0.01(-50.0%) |
| Dec 2022 | 0.02 | 0.02(+100.0%) |
| Sep 2022 | - | 0.01(>+9900.0%) |
| Jun 2022 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 0.00(-100.0%) |
| Dec 2021 | 0.01(-66.7%) | 0.01(0.0%) |
| Sep 2021 | - | 0.01(0.0%) |
| Jun 2021 | - | 0.01(-93.3%) |
| Mar 2021 | - | 0.15(+400.0%) |
| Dec 2020 | 0.03(-137.5%) | 0.03(-121.4%) |
| Sep 2020 | - | -0.14(0.0%) |
| Jun 2020 | - | -0.14(0.0%) |
| Mar 2020 | - | -0.14(+75.0%) |
| Dec 2019 | -0.08(-73.3%) | -0.08 |
| Dec 2018 | -0.30 | - |
FAQ
- What is Inhibikase Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics annual debt to equity year-on-year change?
- What is Inhibikase Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Inhibikase Therapeutics?
- What is Inhibikase Therapeutics quarterly debt to equity year-on-year change?
What is Inhibikase Therapeutics annual debt to equity ratio?
The current annual debt to equity of IKT is 0.02
What is the all time high annual debt to equity for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high annual debt to equity ratio is 0.03
What is Inhibikase Therapeutics annual debt to equity year-on-year change?
Over the past year, IKT annual debt to equity ratio has changed by 0.00 (0.00%)
What is Inhibikase Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of IKT is -0.27
What is the all time high quarterly debt to equity for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high quarterly debt to equity ratio is 0.15
What is Inhibikase Therapeutics quarterly debt to equity year-on-year change?
Over the past year, IKT quarterly debt to equity ratio has changed by -0.30 (-1000.00%)